Physician Introduction on Constipation and Irritable Bowel Syndrome – Pediatric
Presented by Samuel Nurko, MD, MPH
Presentation Overview
There is a very high prevalence of constipation in the pediatric population, with a median range of 8.9% of children being impacted. The quality of life for many children living with constipation can be very low. When abdominal pain with constipation is associated with constipation that does not respond to laxatives, the could be diagnosed with irritable bowel syndrome with constipation (IBS-C). In this presentation, Dr. Samuel Nurko defines constipation and IBS-C, how they are diagnosed, and how constipation and IBS-C can be treated in children today.
About Dr. Nurko
Samuel Nurko, MD, MPH is Director, Center for Motility and Functional Gastrointestinal Disorders; Director, Functional Abdominal Pain Program at Boston Children’s Hospital and Professor of Pediatrics, Harvard Medical School
Dr Nurko was born and raised in Mexico City, where he completed his medical education at the Universidad Nacional Autonoma de Mexico. He completed his pediatric residency at Boston City Hospital and Massachusetts General Hospital, and completed his fellowship in pediatric gastroenterology at Boston Children’s Hospital, where he created the Center for Motility and Functional Bowel Disorders.
Dr Nurko has distinguished himself during his long tenure as an academic, NIH-funded clinical researcher, teacher, mentor, and expert in motility and functional disorders of the gastrointestinal tract in children. He is a recognized leader in the field and has participated in many national and international committees and task forces, including being the Chair of the Neonatal/Toddler Rome IV Committee.
Dr Nurko has made major contributions to the understanding of motility and functional GI disorders in children. His clinical and research interests have focused on understanding the pathophysiology and establishing the best approach and treatments for these disorders, and he has been a pioneer in the development and validation of new techniques to study these disorders in the pediatric population.
